Log In
Print
BCIQ
Print
Print this Print this
 

GKM-001

  Manage Alerts
Collapse Summary General Information
Company Advinus Therapeutics Ltd.
DescriptionActivator of glucokinase (GCK; GK)
Molecular Target Glucokinase (GCK) (GK)
Mechanism of ActionGlucokinase activator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today